These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8980909)

  • 1. Urinary trypsin inhibitor efficiently inhibits urokinase production in tumor necrosis factor-stimulated cells.
    Kobayashi H; Gotoh J; Terao T
    Eur J Cell Biol; 1996 Dec; 71(4):380-6. PubMed ID: 8980909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
    Kobayashi H; Sugino D; Terao T
    Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator.
    Niedbala MJ; Stein-Picarella M
    Blood; 1993 May; 81(10):2608-17. PubMed ID: 7683925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
    Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
    J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of a conjugate between human urokinase and urinary trypsin inhibitor on tumor cell invasion in vitro.
    Kobayashi H; Gotoh J; Hirashima Y; Fujie M; Sugino D; Terao T
    J Biol Chem; 1995 Apr; 270(14):8361-6. PubMed ID: 7713945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
    Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
    Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C synergistically stimulates tumor necrosis factor-alpha-induced secretion of urokinase-type plasminogen activator in human dental pulp cells.
    Hashizume H; Kamio N; Nakao S; Matsushima K; Sugiya H
    J Physiol Sci; 2008 Feb; 58(1):83-6. PubMed ID: 18177545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by gamma-interferon.
    Niedbala MJ; Picarella MS
    Blood; 1992 Feb; 79(3):678-87. PubMed ID: 1732009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
    Niedbala MJ; Stein M
    Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression.
    Li X; Youngblood GL; Payne AH; Hales DB
    Endocrinology; 1995 Aug; 136(8):3519-26. PubMed ID: 7628389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR; Shollenberger SB; Sitrin RG
    J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells.
    Sippy BD; Hofman FM; Wright AD; Wang JL; Gopalakrishna R; Gundimeda U; He S; Ryan SJ; Hinton DR
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):597-606. PubMed ID: 8595959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.
    Aguirre Ghiso JA; Alonso DF; Farías EF; Bal de Kier Joffé E
    Biochim Biophys Acta; 1997 Apr; 1356(2):171-84. PubMed ID: 9150275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A; Knesel J; Fabbro D; Nagamine Y
    J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.